1-1 of 1
Christopher Reynolds
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II study of bendamustine, rituximab, and venetoclax (BR-VEN) for the front-line treatment of Mantle Cell Lymphoma (MCL) in patients ≥60 years old; Updated survival and minimal residual disease (MRD) analysis of precog PrE0405

Free
Craig Portell, Opeyemi Jegede, N. Nora Bennani, Seema Naik, Christopher Reynolds, Priyank Patel, Michael Robertson, Brad Kahl
Journal: Blood
Blood (2025) 146 (Supplement 1): 3574.
https://doi.org/10.1182/blood-2025-3574
Published: 2025